We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$53M
2
NEE icon
NextEra Energy
NEE
+$52.3M
3
CNP icon
CenterPoint Energy
CNP
+$42.7M
4
NI icon
NiSource
NI
+$38.8M
5
EXC icon
Exelon
EXC
+$36.6M

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$47.9M
2
AZN icon
AstraZeneca
AZN
+$38.7M
3
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
+$35.7M
4
VMW
VMware, Inc
VMW
+$32.4M
5
PCGU
PG&E Corporation
PCGU
+$30.6M

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUBO icon
1801
PUT
FuboTV Inc
FUBO
$281M
$81.1K ﹤0.01%
5,583
– –
BCOV
1802
DELISTED
Brightcove, Inc.
BCOV
$79.9K ﹤0.01%
+17,966
New +$100K
SIRI icon
1803
CALL
SiriusXM
SIRI
$10.4B
$79.4K ﹤0.01%
2,000
-12,670
-86% -$607K
LUMN icon
1804
Lumen
LUMN
$6.91B
$78.2K ﹤0.01%
29,512
-59,460
-67% -$240K
GPMT
1805
Granite Point Mortgage Trust
GPMT
$70M
$78.1K ﹤0.01%
+15,750
New +$91.7K
ABUS icon
1806
Arbutus Biopharma
ABUS
$873M
$76.9K ﹤0.01%
+25,371
New +$71.6K
ORIC icon
1807
Oric Pharmaceuticals
ORIC
$1.39B
$76K ﹤0.01%
+13,325
New +$69.6K
CMPX icon
1808
Compass Therapeutics
CMPX
$357M
$75.4K ﹤0.01%
+23,062
New +$90.5K
VRCA icon
1809
Verrica Pharmaceuticals
VRCA
$92.9M
$73.2K ﹤0.01%
+1,126
New +$68.1K
RIG icon
1810
Transocean
RIG
$5.78B
$73.1K ﹤0.01%
+11,500
New +$73.8K
LUCD icon
1811
Lucid Diagnostics
LUCD
$183M
$70.6K ﹤0.01%
50,462
+14,296
+40% +$19.8K
JGGCR
1812
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$70K ﹤0.01%
409,511
-35,174
-8% -$4.97K
CLINR
1813
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$68.8K ﹤0.01%
459,900
– –
PFSW
1814
DELISTED
PFSweb, Inc.
PFSW
$68.3K ﹤0.01%
+16,100
New +$99.6K
GFGDR
1815
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$67.5K ﹤0.01%
374,900
– –
ABSI icon
1816
Absci
ABSI
$1.44B
$62.7K ﹤0.01%
+35,826
New +$86.7K
TDAY
1817
USA Today Co
TDAY
$1.32B
$62.6K ﹤0.01%
+33,454
New +$78.4K
AIM
1818
AIM ImmunoTech
AIM
$7.29M
$61.9K ﹤0.01%
1,441
-91
-6% -$4.72K
ARC
1819
DELISTED
ARC Document Solutions, Inc.
ARC
$61.5K ﹤0.01%
+19,400
New +$64.8K
MNKD icon
1820
MannKind Corp
MNKD
$1.22B
$59.5K ﹤0.01%
14,500
-8,127
-36% -$39.2K
SABR icon
1821
Sabre
SABR
$838M
$59.2K ﹤0.01%
13,788
+3,514
+34% +$20.1K
IMMP
1822
Immutep
IMMP
$58M
$58.8K ﹤0.01%
35,000
– –
PRCH icon
1823
Porch Group
PRCH
$1.87B
$58.4K ﹤0.01%
+40,812
New +$96.7K
ICVX
1824
DELISTED
Icosavax, Inc. Common Stock
ICVX
$58.3K ﹤0.01%
+10,058
New +$86.9K
NETC.WS
1825
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$58.2K ﹤0.01%
280,997
– –
71 72
73
74 75

Similar funds

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
UM
UniSuper Management Melbourne, Victoria, Australia $15.3B AUM 29.4% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.